Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

EverFit Medical vs NowPatient

EverFit Medical
Graded #382

Lower grade

vs+7.5
NowPatient
Graded #222

Higher grade

The verdict

NowPatient takes it — 65.5/100 to 58/100.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEverFit Medical +10
45
35
Dose & formulationNowPatient +53
40
93
Clinical oversightEven
86
86
Labs & monitoringEverFit Medical +9
63
54
FulfillmentNowPatient +6
64
70
Contract termsEven
55
55
EverFit Medical · left barNowPatient · right bar

The numbers

MetricEverFit MedicalNowPatient
WeighScore58/10065.5/100
GradeCC
Scorecard rank#382#222
SemaglutideNot disclosed$1,349/mo (brand Wegovy)
TirzepatideNot disclosed$1,069/mo (brand Mounjaro, promotional rate)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
EverFit Medical

Graded #382 · C

Strengths

  • Named owner publicly disclosed (Carrie Zatelli) — uncommon in this segment
  • Physical clinic address published (Macedonia, Ohio)
  • Direct phone and email published for human contact
  • Hybrid model: Ohio in-person clinic for body scans and red-light therapy plus 50-state telehealth
  • Plan includes evaluation, treatment plan, medication when appropriate, and optional nutrition coaching

Where it loses points

  • Conflicting scope: hero claims all 50 states, but footer says services are Ohio-only — the 50-state track runs through partner group Dr Telx
  • Pricing not published — gated behind a phone assessment
  • Owner's clinical credentials (PA, RN, MD?) not stated
  • Telehealth patients are treated by partner group Dr Telx, not EverFit itself — relationship isn't fully transparent
  • No LegitScript or NABP .pharmacy seal displayed
NowPatient

Graded #222 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard